|
TSPAN14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.871600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.119700E-02 |
| Normal-vs-Stage2 |
5.113600E-01 |
| Normal-vs-Stage3 |
1.807600E-02 |
| Normal-vs-Stage4 |
5.440700E-03 |
| Stage1-vs-Stage2 |
1.641850E-02 |
| Stage1-vs-Stage3 |
2.19919999988605E-08 |
| Stage1-vs-Stage4 |
2.59460000151535E-08 |
| Stage2-vs-Stage3 |
2.528600E-01 |
| Stage2-vs-Stage4 |
9.841800E-02 |
| Stage3-vs-Stage4 |
4.740200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.552800E-01 |
| Normal-vs-AfricanAmerican |
3.710200E-01 |
| Normal-vs-Asian |
7.901800E-01 |
| Caucasian-vs-AfricanAmerican |
2.065000E-01 |
| Caucasian-vs-Asian |
7.599200E-01 |
| AfricanAmerican-vs-Asian |
5.132000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.493000E-01 |
| Normal-vs-Female |
4.697000E-01 |
| Male-vs-Female |
1.395040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.517200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.710000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.184600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.207900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.824200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.463200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.712200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.144820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.599620E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.542580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.118000E-03 |
| Normal-vs-Grade 2 |
1.545820E-02 |
| Normal-vs-Grade 3 |
2.113800E-02 |
| Normal-vs-Grade 4 |
1.702770E-03 |
| Grade 1-vs-Grade 2 |
2.101800E-03 |
| Grade 1-vs-Grade 3 |
4.770500E-04 |
| Grade 1-vs-Grade 4 |
3.25589999405906E-09 |
| Grade 2-vs-Grade 3 |
1.82390003100608E-09 |
| Grade 2-vs-Grade 4 |
3.6930000169022E-09 |
| Grade 3-vs-Grade 4 |
1.399360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.703660E-02 |
| Normal-vs-ccB subtype |
7.694400E-02 |
| ccA subtype-vs-ccB subtype |
1.07469999999221E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.121600E-01 |
| Normal-vs-N1 |
1.220600E-01 |
| N0-vs-N1 |
3.372800E-01 |
|
|
